In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.


on COVID-19 and CVD


Contrary to its initial characterisation as primarily a respiratory disease, COVID-19 affects many organ systems, notably the cardiovascular system. From myocardial injury and thrombosis to arrhythmia and the emerging phenomenon of long COVID, COVID-19 remains a pervasive risk, not only for individuals with pre-existing cardiovascular diseases but also for those previously healthy, who may develop cardiovascular conditions as a consequence of the virus.

This month’s FOCUS provides carefully selected resources on the latest clinical research and best practices around COVID-19 and cardiovascular disease. Our mission is to create awareness, disseminate knowledge, and provide practical tools essential for navigating the complexities of managing COVID-19, including effective patient communication and continuous engagement with evolving research. Join us in this collaborative effort as we sharpen our focus on the dynamic interplay between COVID-19 and cardiovascular disease.

The content below, selected by Ronen Beeri, Yan Topilsky and Vanessa Lopes, will help you expand your knowledge of COVID-19. 




COVID-19 and CVD: most recent updates
12 March 2024
With Guido Tavazzi, Vanessa Lopes and Yan Xie

Guidance on communication skills for GPs and primary care specialists
20 March 2024
With Jordi Baneras Rius, Goncalo Costa, Cristina Gavina and Michelle Kittleson

Dig deeper

Exclusive for members